Geron to Present at the Needham Healthcare Conference
MENLO PARK, Calif., April 24, 2013 - Geron Corporation (Nasdaq: GERN) today announced that John Scarlett, M.D., President and Chief Executive Officer, will present an overview of the company at 10:00 a.m. Eastern Time on Wednesday, May 1, at the Needham 12th Annual Healthcare Conference in New York City.
A live webcast of the presentation will be available at http://wsw.com/webcast/needham58/gern/. Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.
About Geron
Geron is a biopharmaceutical company developing first-in-class therapies for cancer, including its telomerase inhibitor, imetelstat, in clinical development. For more information about Geron, visit www.geron.com.
CONTACT:
Anna Krassowska, Ph.D.
Investor and Media Relations
650-473-7765
investor@geron.com
media@geron.com
###